Healthcare Services

Global Common Warts Market Expected to Reach $2.95 Billion by 2030 with 5.6% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Common Warts Market By The End Of 2030?

The common warts market size has experienced robust growth in recent years. This market is anticipated to expand from $2.25 billion in 2025 to $2.38 billion in 2026, driven by a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this historical growth include the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, availability of topical salicylic acid products, expansion of dermatology clinics, and heightened awareness of skin health.

The common warts market is anticipated to demonstrate significant expansion in the foreseeable future, with projections indicating it will reach $2.96 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.6%. This rise during the forecast period is fueled by several factors, including the increasing desire for non-invasive dermatological solutions, a heightened interest in cosmetic dermatology, the growth of homecare dermatology products, the rising acceptance of laser-based treatments, and increased financial input into immunomodulatory therapies. Notable developments expected in this period encompass improvements in minimally invasive wart removal techniques, an increase in the application of combination therapy strategies, wider availability of over-the-counter treatments, an expanding use of immunotherapy-based topical applications, and the proliferation of home-based treatment choices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Primary Drivers Are Shaping The Development Of The Common Warts Market?

The common warts market is projected for growth due to the escalating occurrence of viral infections. Viral infections are defined as illnesses caused by viruses entering, multiplying, and spreading within the body, impacting cells and immune responses. The rising frequency of viral infections is influenced by globalization, climate change, urbanization, deforestation, and compromised immune responses. Treatment for common warts targets the human papillomavirus (HPV) responsible for their formation, offering crucial support to viral infection patients by reducing viral spread, alleviating discomfort, and promoting healing, thereby preventing complications like secondary infections or scarring while enhancing the patient’s quality of life. For instance, in 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, the proportion of PCR-confirmed varicella cases increased by 62%, growing from 29% to 47% over the past five years. Furthermore, in January 2023, according to the National Foundation for Infectious Diseases, a US-based health organization, an estimated 14 million new cases of HPV infection occur annually in the United States. Therefore, the increasing incidence of viral infections is driving expansion in the common warts market.

Which Segment Classifications Shape The Common Warts Market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

What Major Market Trends Are Driving Changes In The Common Warts Market?

Leading firms in the common warts market are prioritizing the development of innovative treatments, including dermatological therapies, in response to the increasing need for effective and readily available solutions, with the goal of enhancing patient results and broadening their footprint in dermatology. These therapies address various skin conditions, such as infections, inflammations, and other disorders. An example of this is the license agreement established in May 2024 between Verrica Pharmaceuticals, a US-based pharmaceutical entity, and Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical entity. This partnership is designed to finance a worldwide Phase 3 clinical trial for YCANTH, which treats common warts. The agreement facilitates the late-stage development of YCANTH, thereby extending its potential global accessibility. Torii Pharmaceuticals is set to provide financial backing to progress the study. This collaboration enhances the dermatology portfolios and international market presence of both companies.

Which Companies Are Expanding Their Footprint In The Common Warts Market?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Read the full common warts market report here:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

How Does The Common Warts Market Perform Across Major Global Regions?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Common Warts Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Chronic Cough Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Cold Pain Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Cold Plasma Global Market Report

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795